Komori
Eisai (4523) · InitiativeFirst stated

Absorption-type merger of Morphotek by Eisai Inc.

First written in FY2019-Q3. . Latest entry: FY2019-Q3.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Integration of the R&D Structure and Productivity Improvement through Morphotek Absorption MergerA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2019-Q3First statedAnnual report

    「なお、2019年1月、当社グループ内の連携強化および生産性向上を企図して、医薬品の研究開発・製造・販売子会社であるEisai Inc.(米国)は、医薬品の研究開発子会社であるMorphotek, Inc.(米国)を吸収合併しました。」

    グループ内の連携強化と生産性向上を目的として、Eisai Inc.が研究開発子会社Morphotekを吸収合併した。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Eisai yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Absorption-type merger of Morphotek by Eisai Inc. | Eisai Co.,Ltd. (4523) | Komori